Creative Touch Permanent Makeup and Aesthetics

Thyroid dysfunction – encompassing hypothyroidism, hyperthyroidism, and their autoimmune variants – produces some of the most diagnostically informative cutaneous changes of any endocrine condition, with measurable skin or hair findings present in 80–86% of patients with thyroid disease. The presentations of hypothyroidism and hyperthyroidism are characteristically opposite: insufficient T3 signalling slows epidermal turnover, reduces fibroblast activity, impairs anagen prolongation, and allows glycosaminoglycan accumulation in the dermis; excess T3 signalling accelerates these same processes, producing a warm, moist, thin-skinned presentation alongside accelerated hair cycling and nail changes. Both states are clinically relevant in aesthetics practice – as causes of treatment underperformance, as differentials for presenting skin and hair complaints, and as conditions that may be subclinical and undiagnosed at the point of consultation. The selenium→deiodinase→T3 chain means that nutritional depletion – including post-GLP-1 RA dietary restriction – can produce functional hypothyroidism at tissue level without abnormal TSH or T4 on standard screening.

The mechanistic basis for thyroid dysfunction’s cutaneous consequences is established in the Thyroid Hormone entity: T3 drives keratinocyte proliferation, fibroblast activity, GAG suppression, and anagen prolongation through nuclear receptor-mediated gene expression. Dysfunction in either direction – too little or too much – produces skin changes that are the direct reversal or amplification of those normal regulatory effects. Because the presentations are mechanistically opposite, they are clinically distinctive: a practitioner familiar with the mechanisms can often identify thyroid dysfunction from skin and hair presentation before blood results are available.

Hypothyroidism: Skin and Hair

Hypothyroidism – insufficient thyroid hormone production relative to tissue requirements – produces a consistent and recognisable cutaneous picture driven by reduced T3 signalling across keratinocytes, fibroblasts, and hair follicles simultaneously.

Skin texture and barrier: Reduced keratinocyte proliferation slows epidermal turnover, producing dry, rough, coarse skin – xerosis – reported in approximately 67–68% of hypothyroid patients. The stratum corneum thickens as desquamation slows; skin takes on a pale, yellowish, or dull appearance. Reduced eccrine gland activity decreases sweating, compounding surface dryness. The pallor reflects reduced peripheral circulation and, in some cases, carotenaemia – carotene accumulates in skin when its hepatic conversion to vitamin A is slowed by reduced thyroid hormone-driven metabolic activity. ^[1]

Myxoedema: The loss of T3-mediated suppression of glycosaminoglycan production in dermal fibroblasts allows hyaluronic acid, chondroitin sulphate, and other GAGs to accumulate in the dermis. GAGs are strongly hygroscopic – they attract and retain water – producing the characteristic non-pitting, doughy oedema of myxoedema, most visible periorbitally and on the dorsal hands. This is not inflammatory oedema and does not respond to diuretics; it resolves with thyroid hormone replacement. The mechanism is directly opposite to the GAG suppression that adequate T3 maintains. ^[6]

Fibroblast activity and collagen: Reduced TR-mediated fibroblast proliferation and collagen synthesis produces a dermis that is structurally compromised – thin, poorly supported, slow to remodel and repair. In the aesthetics context, this is the primary treatment responsiveness implication: collagen-stimulating procedures depend on fibroblast responsiveness that hypothyroidism directly reduces.

Hair: Telogen effluvium is among the most common and distressing features of hypothyroidism, affecting approximately 65–66% of patients. The mechanism is the loss of T4-mediated TGF-β2 suppression: without adequate thyroid hormone prolonging anagen, follicles shift prematurely to catagen and then telogen, producing diffuse hair thinning across the scalp. The characteristic loss of the outer third of the eyebrows – Queen Anne’s sign – reflects the same mechanism in terminal eyebrow follicles, which are particularly sensitive to T3 withdrawal. Intrafollicular melanin synthesis is also reduced, contributing to premature hair greying or colour dulling that may precede the hair loss itself. ^[9]

Nails: Slow-growing, brittle, thickened nails reflect reduced keratinocyte proliferation in the nail matrix – the same mechanism as epidermal slowing, applied to nail plate production.

Hyperthyroidism: The Opposite Presentation

Hyperthyroidism – excess T3/T4 relative to tissue requirements – accelerates the same cellular processes that hypothyroidism slows, producing a presentation that is in almost every respect the clinical inverse.

Skin texture: Increased keratinocyte turnover produces warm, smooth, moist, velvety skin – described as resembling infantile skin in texture – the tactile opposite of hypothyroid xerosis. Increased eccrine and apocrine gland activity produces hyperhidrosis, reported in 64–80% of hyperthyroid patients across clinical series. Warm skin temperature and palmar erythema reflect peripheral vasodilation driven by thyroid hormone-mediated increases in cardiac output and peripheral blood flow, with palmar erythema present in 35–48% of patients. ^[5]

Hyperpigmentation: Diffuse hyperpigmentation is reported in 38–52% of hyperthyroid patients across cohorts. The mechanism is multifactorial: elevated ACTH – secreted by the pituitary to compensate for accelerated cortisol degradation in thyrotoxicosis – activates the type 1 melanocortin receptor (MC-1R) on melanocytes via the cAMP second messenger pathway, driving melanin overproduction. In Graves’ disease specifically, stimulating TSH receptor antibodies acting on functionally expressed TSH receptors in epidermal melanocytes provide a second, independent pigmentation drive. The pigmentation tends to be diffuse rather than focal, and is mechanistically distinct from the focal pigmentation of Addison’s disease despite superficial similarity. ^[8]

Hair: Fine, thin, soft hair – and paradoxically diffuse hair loss – characterises hyperthyroidism, reported in approximately 22–54% of patients. The mechanism is distinct from hypothyroid telogen effluvium: in hyperthyroidism, accelerated hair cycling shortens individual anagen duration despite rapid turnover, producing a net reduction in hair density. The texture change – from the coarse, dry hair of hypothyroidism to fine, silky, fragile hair – is diagnostically useful. ^[2]

Onycholysis: Separation of the nail plate from the nail bed – Plummer’s nails – is present in approximately 28–36% of hyperthyroid patients and is sufficiently characteristic that unexplained onycholysis should prompt thyroid investigation. The mechanism involves increased peripheral blood flow to the nail bed and accelerated distal nail growth producing progressive distal separation, typically beginning at the middle or ring fingers. ^[4]

The Autoimmune Dimension

The majority of thyroid dysfunction in the UK population is autoimmune in origin. Hashimoto’s thyroiditis – autoimmune destruction of thyroid follicular cells – is the most common cause of hypothyroidism; Graves’ disease – TSH receptor-stimulating autoantibodies driving unregulated thyroid hormone production – is the most common cause of hyperthyroidism. Both conditions carry a significantly elevated risk of co-occurring autoimmune skin conditions, with cutaneous manifestations present in the majority of autoimmune thyroid disorder patients in clinical series.

The most clinically significant autoimmune skin co-occurrences, from a cross-sectional study of 400 thyroid disorder patients, include: ^[9]

• Urticaria – the most common autoimmune association, present in approximately 33% of patients
• Vitiligo – melanocyte autoimmune destruction; co-occurrence approximately 11–12%
• Alopecia areata – follicular autoimmune attack; co-occurrence approximately 6%
• Pretibial myxoedema – specific to Graves’ disease; TSH receptor antibodies stimulate dermal fibroblast GAG production in the pretibial skin, independent of circulating thyroid hormone levels; mechanistically distinct from the generalised myxoedema of hypothyroidism

Prevalence figures from tertiary care cohorts may differ from UK community populations, but the directional associations are consistent across the broader literature. The autoimmune clustering reflects shared immune dysregulation – particularly HLA-DR associations and regulatory T-cell dysfunction – that predisposes to autoimmunity across multiple tissue targets simultaneously. ^[1]

Subclinical Dysfunction: Skin Before the Diagnosis

Subclinical hypothyroidism – defined as elevated TSH with T3 and T4 within the reference range – represents a state of early compensatory response in which the pituitary is already signalling insufficient thyroid output, but circulating hormone levels have not yet fallen below the laboratory threshold. Skin and hair consequences may already be measurable at this stage.

A 2024 case series published in PMC examined subclinical hypothyroidism and skin hyperpigmentation – a presentation not typically associated with hypothyroidism – and found resolution of treatment-resistant hyperpigmentation following levothyroxine initiation in patients who had been subclinically hypothyroid. The mechanism is presumed to involve TSH’s structural similarity to MSH and its ability to stimulate melanocortin receptors at elevated concentrations – a secondary effect of TSH excess rather than a direct thyroid hormone skin effect. This finding has direct aesthetics relevance: a client presenting with treatment-resistant pigmentation that is not responding to standard protocols may have subclinical hypothyroidism as an unrecognised upstream driver. ^[7]

The Selenium–Deiodinase–Thyroid Chain

The most clinically underappreciated pathway connecting thyroid function to aesthetics practice is the selenium→deiodinase→T3 chain. DIO1 and DIO2 – the enzymes responsible for peripheral T4→T3 conversion – are selenoproteins, requiring selenocysteine at their active site for catalytic function. Selenium deficiency reduces deiodinase activity, impairing T4→T3 conversion and producing elevated T4 with reduced T3 – a pattern that standard TSH-only or TSH+T4 screening will not identify as pathological. ^[3]

The dietary connection is direct. Selenium is found predominantly in animal proteins – organ meat, seafood, eggs, Brazil nuts – and its bioavailability is dependent on soil selenium content, which is notably low across much of the UK and Northern Europe. Individuals on highly restrictive dietary patterns, those who have undergone rapid weight loss on GLP-1 RA medications without nutritional monitoring, or those on long-term calorie-restricted diets may have suboptimal selenium intake producing measurable impairment of T4→T3 conversion.

The clinical chain is: dietary selenium depletion → reduced DIO2 activity → reduced intracellular T3 in skin and hair follicles → reduced fibroblast collagen synthesis → reduced keratinocyte turnover → impaired anagen → poor treatment responsiveness and hair thinning. Each step is individually evidenced; the complete chain as a clinical entity in nutritionally depleted aesthetics clients is clinically plausible and underrecognised. Selenium status testing (plasma selenoprotein P or whole blood selenium) is not routine in aesthetics practice, but it is a low-cost investigation that may explain a cluster of treatment-resistant presentations.